| CO-1686 |
CO1686 |
1374640-70-6 |
| BRD4770 |
2-苯甲酰胺基-1-(3-苯丙基)-1H-苯并[D]咪唑-5-羧酸甲酯 |
1374601-40-7 |
| pf-5274857 |
PF-5274857 |
1373615-35-0 |
| ON123300 |
8-环戊基-7,8-二氢-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-7-氧代-吡啶并[2,3-D]嘧啶-6-甲腈 |
1357470-29-1 |
| N-cyclohexyl-2-(N-(3-fluorophenyl)-2-(2-Methyl-1H-iMidazol-1-yl)acetaMido)-2-(o-tolyl)acetaMide |
AGI-5198 (IDH-C35) |
1355326-35-0 |
| EW-7197 |
EW-7197 |
1352608-82-2 |
| MK5172 |
格佐匹韦 |
1350514-68-9 |
| CID-49830258 |
ML240 |
1346527-98-7 |
| S)-1-(sec-butyl)-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-3-Methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxaMide |
GSK126 |
1346574-57-9 |
| E6446 (dihydrochloride) |
CS-2089 |
1345675-25-3 |
| INCB8761(PF-4136309) |
INCB8761(PF-4136309) |
1341224-83-6 |
| PI3K/HDAC Inhibitor |
CUDC-907 |
1339928-25-4 |
| N-(5-(1-(2,6-dichlorophenyl)-3-(difluoroMethyl)-1H-pyrazol-5-yl)thiazol-2-yl)cyclopropanecarboxaMide |
BMS-3 |
1338247-30-5 |
| azd4635 |
AZD4635 |
1321514-06-0 |
| ACY-1215 |
ACY1215 |
1316214-52-4 |
| Tubastatin A hydrochloride |
Tubastatin A盐酸盐 |
1310693-92-5 |
| GDC-0032 |
GDC 0032 |
1282512-48-4 |
| LY 2874455 |
LY2874455 |
1254473-64-7 |
| E3 ligase Ligand-Linker Conjugates 17 |
1950635-16-1 |
1950635-16-1 |
| ARV-771 |
ARV-771 |
1949837-12-0 |
QQ
微信
